Stepstone Group LP
StepStone Group LP is a leading global private markets asset manager, headquartered in New York, NY. Founded in 2006, the firm offers customized investment, portfolio monitoring, and advisory solutions to a wide range of institutional investors worldwide, including pension funds, sovereign wealth funds, and family offices. StepStone covers primary funds, secondaries, and co-investments across private equity, real estate, infrastructure, and private debt. The firm employs over 1,160 professionals across 29 offices globally, serving clients with deep expertise and data-driven approaches to private markets investing.
Investment Strategy
StepStone Group employs a multi-strategy approach across the entire spectrum of private markets, including private equity, venture capital, private debt, real estate, and real assets. The firm constructs custom portfolios through primaries, secondaries, and co-investments, leveraging data-rich insights and rigorous analytics to source, evaluate, and execute investments globally. StepStone focuses on being an active owner, curating investment opportunities that offer superior risk-adjusted returns and low correlation with public markets. ESG considerations and responsible investment are integral to their long-term outlook, allowing thorough risk management and future-focused capital deployment.
Top Holdings
Equity Positions (14)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
P PATH | UIPATH, INC. | 32.65% | $16.5M | 1,286,527 | $52.07 | $12.80 | +$3.2M |
D DKNG | DRAFTKINGS INC | 18.25% | $9.2M | 214,536 | $39.20 | $42.89 | +$2.1M |
R RBRK | RUBRIK, INC. | 10.69% | $5.4M | 60,182 | $64.00 | $89.59 | +$2.1M |
T TRDA | ENTRADA THERAPEUTICS, INC. | 10.14% | $5.1M | 761,277 | $16.89 | $6.72 | -$1.8M |
P PHAT | PHATHOM PHARMACEUTICALS, INC. | 8.03% | $4.0M | 422,085 | $32.10 | $9.59 | +$1.4M |